GuidelineClinical infectious diseases : an official publication of the Infectious Diseases Society of America2003
Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults.
Guideline in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00434291 (A Randomized, Double-Blind, Comparative, Multi-Center Study of the Safety and Efficacy of TG-873870), which is not on this map. Cited by 208 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Randomized, Double-Blind, Comparative, Multi-Center Study of the Safety and Efficacy of TG-873870(Nemonoxacin) Versus Levofloxacin in Adult Patients With Community-Acquired Pneumonia (CAP)
Who cites it
208 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- Predictors of mortality for nursing home-acquired pneumonia: a systematic review.BioMed research international · 2015Pooled it
- Antibiotics for community-acquired pneumonia in adult outpatients.The Cochrane database of systematic reviews · 2014Pooled it
- Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2007Guideline
- Efficacy and safety of sequential moxifloxacin for treatment of community-acquired pneumonia associated with atypical pathogens.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2004Pooled it
- Processes of care and outcomes for community-acquired pneumonia.The American journal of medicine · 2011Trial
- Pharmacokinetics of solithromycin (CEM-101) after single or multiple oral doses and effects of food on single-dose bioavailability in healthy adult subjects.Antimicrobial agents and chemotherapy · 2011Trial
- Accuracy of C-reactive protein, procalcitonin, and mid-regional pro-atrial natriuretic peptide to guide site of care of community-acquired pneumonia.Intensive care medicine · 2010Trial
- Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia.BMC pulmonary medicine · 2009Trial
- Ciprofloxacin dosage and emergence of resistance in human commensal bacteria.The Journal of infectious diseases · 2009Trial
- Serum zinc and pneumonia in nursing home elderly.The American journal of clinical nutrition · 2007Trial
- Ertapenem versus cefepime for initial empirical treatment of pneumonia acquired in skilled-care facilities or in hospitals outside the intensive care unit.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2006Trial
- Factors associated with the hospitalization of low-risk patients with community-acquired pneumonia in a cluster-randomized trial.Journal of general internal medicine · 2006Trial
- Comparing gatifloxacin and clarithromycin in pneumonia symptom resolution and process of care.Antimicrobial agents and chemotherapy · 2006Trial
- Novel, single-dose microsphere formulation of azithromycin versus 7-day levofloxacin therapy for treatment of mild to moderate community-acquired Pneumonia in adults.Antimicrobial agents and chemotherapy · 2005Trial
- Double-blind, randomized study of the efficacy and safety of oral pharmacokinetically enhanced amoxicillin-clavulanate (2,000/125 milligrams) versus those of amoxicillin-clavulanate (875/125 milligrams), both given twice daily for 7 days, in treatment of bacterial community-acquired pneumonia in adults.Antimicrobial agents and chemotherapy · 2004Trial
- Prulifloxacin.Drugs · 2004Trial
- Assessment of Compliance with National and International Guidelines in the Empirical Management of Community-Acquired Pneumonia (CAP) in Lebanese Hospitals: A Multicenter Retrospective Cohort Study.Antibiotics (Basel, Switzerland) · 2026Article
- Clinical and Epidemiologic Features ofInternational journal of medical sciences · 2024Article
- The role of empiric atypical antibiotic coverage in non-severe community-acquired pneumonia.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2024Review
- Meningitis in critically ill patients admitted to intensive care unit for severe community-acquired pneumococcal pneumonia.Annals of intensive care · 2023Article
148 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.